Delta(B.1.617.2)inactivated vaccine candidate elicited neutralizing antibodies to SARS-CoV-2 and circulating variants in rhesus macaques  

作　　者：Yanjun Zhang Haiyan Mao Ju Li Jianhua Li Chen Huang Jiaxuan Li Minglei Chu Fengbo Xue Linhui Wang Zhongbiao Fang Zhen Wang Jinan Wu Keda Chen 

机构地区：[1]Key Laboratory of Public Health Detection and Etiological Research of Zhejiang Province,Department of Microbiology,Zhejiang Provincial Center for Disease Control and Prevention,Hangzhou,310051,China [2]Rong an Bio-pharmaceutical Co,Ltd.,Ningbo,315000,China [3]Shulan International Medical College,Zhejiang Shuren University,Hangzhou,310000,China

出　　处：《Virologica Sinica》2023年第4期627-630,共4页中国病毒学（英文版）

基　　金：supported by the Science and Technology Program of Zhejiang Province (#2022C03017);Key Research and Development Program of Zhejiang Province (#2021C03044);Major Health Science and Technology Projects of Zhejiang Province (#WKJ-ZJ-2105);National Key R&D Program of China (#2021YFC2301200).

摘　　要：Dear Editor,The coronavirus disease 2019(COVID-19)pandemic has resulted in 763 million cases and over 6 million deaths as of April 2023.Given the high prevalence and widespread distribution of coronaviruses,the genetic diversity and frequent recombination of their genomes,as well as the increased activity at the human-animal interface,are critical for global public health and socioeconomic impact(Zhu et al.,2020).

关 键 词：ANTIBODIES VACCINE 

分 类 号：R373[医药卫生—病原生物学]